Loading
HKSEHealthcareBiotechnology
Latest quote
HK$2.485
−HK$0.035 · -1.39%
Zhaoke Ophthalmology Limited is an ophthalmic pharmaceutical company dedicated to researching, developing, and commercializing therapeutic solutions addressing significant unmet medical requirements in the People's Republic of China. The company is advancing a range of medications designed for various ocular conditions, impacting both the anterior and posterior segments of the eye, such as dry eye disease, wet age-related macular degeneration, diabetic macular edema, myopia, and glaucoma. It was previously known as China Ophthalmology Focus Limited. Zhaoke Ophthalmology Limited was established in 2017 and operates from its headquarters in Guangzhou, People's Republic of China.
Latest quote
HK$2.485
−HK$0.035 · -1.39%
Regular session · HKT · Market data may be delayed.
Zhaoke Ophthalmology Limited is an ophthalmic pharmaceutical company dedicated to researching, developing, and commercializing therapeutic solutions addressing significant unmet medical requirements in the People's Republic of China. The company is advancing a range of medications designed for various ocular conditions, impacting both the anterior and posterior segments of the eye, such as dry eye disease, wet age-related macular degeneration, diabetic macular edema, myopia, and glaucoma. It was previously known as China Ophthalmology Focus Limited. Zhaoke Ophthalmology Limited was established in 2017 and operates from its headquarters in Guangzhou, People's Republic of China.
Day range
Current HK$2.485
52-week range
Current HK$2.485
Regular session · HKT · Market data may be delayed.
Zhaoke Ophthalmology Limited is an ophthalmic pharmaceutical company dedicated to researching, developing, and commercializing therapeutic solutions addressing significant unmet medical requirements in the People's Republic of China. The company is advancing a range of medications designed for various ocular conditions, impacting both the anterior and posterior segments of the eye, such as dry eye disease, wet age-related macular degeneration, diabetic macular edema, myopia, and glaucoma. It was previously known as China Ophthalmology Focus Limited. Zhaoke Ophthalmology Limited was established in 2017 and operates from its headquarters in Guangzhou, People's Republic of China.
Day range
Current HK$2.485
52-week range
Current HK$2.485
Profitability as a percentage of reported revenue.
Revenue
Operating income
Net income
| Metric (CNY) | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 31.15M CNY | 69.32M CNY | 18.75M CNY | — | — |
| Cost of goods sold | 63.71M CNY | 17.53M CNY | 4.5M CNY | — | — |
| Gross profit | −32.57M CNY | 51.8M CNY | 14.25M CNY | — | — |
| Research and development | 132.46M CNY | 203.7M CNY | 333.05M CNY | 296.43M CNY | 220.06M CNY |
| Selling, general, and administrative | 36.86M CNY | 134.28M CNY | 43.16M CNY | 48.09M CNY | 65.45M CNY |
| Operating expenses | 233.85M CNY | 279.79M CNY | 390.81M CNY | 405.01M CNY | 364.33M CNY |
| Interest income | 43.22M CNY | 75.23M CNY | 77.4M CNY | 30.42M CNY | 5.04M CNY |
| Interest expense | 8.85M CNY | 9.5M CNY | 7.92M CNY | 3.14M CNY | 1.95M CNY |
| Depreciation and amortization | 50.97M CNY | 33.68M CNY | 48.7M CNY | 27.78M CNY | 21.34M CNY |
| Operating income | −266.41M CNY | −227.99M CNY | −376.57M CNY | −404.18M CNY | −364.33M CNY |
| Net income | −203.57M CNY | −237.49M CNY | −385.04M CNY | −407.32M CNY | −2.13B CNY |
Company facts updated Sep 9, 2026.
Recent quarterly results
Recent quarterly results
AI-generated and delayed market data for informational and educational purposes only. Not investment advice.
